The mRNA levels of FGFR2 and SPRY2 were detected by quantitative PCR in 11 samples of gastric adenocarcinoma, including tumor tissues, adjacent tumor tissues and invaded lymph nodes. The gene discussed is SPRY2; the disease is gastric adenocarcinoma.